Skip to main content
Top
Published in: BMC Public Health 1/2018

Open Access 01-12-2018 | Study protocol

Evaluating the impact of DREAMS on HIV incidence among young women who sell sex: protocol for a non-randomised study in Zimbabwe

Authors: Bernadette Hensen, James R. Hargreaves, Tarisai Chiyaka, Sungai Chabata, Phillis Mushati, Sian Floyd, Isolde Birdthistle, Joanna Busza, Frances Cowan

Published in: BMC Public Health | Issue 1/2018

Login to get access

Abstract

Background

“Determined, Resilient, AIDS-free, Mentored and Safe” (DREAMS) is a package of biomedical, social and economic interventions offered to adolescent girls and young women aged 10–24 years with the aim of reducing HIV incidence. In four of the six DREAMS districts in Zimbabwe, DREAMS includes an offer of oral pre-exposure prophylaxis (DREAMS+PrEP), alongside interventions to support demand and adherence, to women aged 18–24 who are at highest risk of HIV infection, including young women who sell sex (YWSS). This evaluation study addresses the question: does the delivery of DREAMS+PrEP through various providers reduce HIV incidence among YWSS Zimbabwe? We describe our approach to designing a rigorous study to assess whether DREAMS+PrEP had an impact on HIV incidence.

Methods

The study design needed to account for the fact that: 1) DREAMS+PrEP was non-randomly allocated; 2) there is no sampling frame for the target population for the evaluation; 3) there are a small number of DREAMS districts (N = 6), and 4) DREAMS+PrEP is being implemented by various providers. The study will use a cohort analysis approach to compare HIV incidence among YWSS in two DREAMS+PrEP districts to HIV incidence among YWSS in non-DREAMS comparison sites. YWSS will be referred to services and recruited into the cohort through a network-based (respondent-driven) recruitment strategy, and followed-up 12- and 24-months after enrolment. Women will be asked to complete a questionnaire and offered HIV testing. Additional complications of this study include identifying comparable populations of YWSS in the DREAMS+PrEP and non-DREAMS comparison sites, and retention of YWSS over the 24-month period. The primary outcome is HIV incidence among YWSS HIV-negative at study enrolment measured by repeat, rapid HIV testing over 24-months. Inference will be based on plausibility that DREAMS+PrEP had an impact on HIV incidence. A process evaluation will be conducted to understand intervention implementation, and document any contextual factors determining the success or failure of intervention delivery.

Discussion

HIV prevention products of known efficacy are available. Innovative studies are needed to provide evidence of how to optimise product use through combination interventions to achieve population impact within different contexts. We describe the design of such a study.
Literature
2.
go back to reference Joint United Nations Programme on HIV/AIDS (UNAIDS). The prevention gap report. 2016. Joint United Nations Programme on HIV/AIDS (UNAIDS). The prevention gap report. 2016.
6.
go back to reference George A, Sabarwal S. Sex trafficking, physical and sexual violence, and HIV risk among young female sex workers in Andhra Pradesh, India. Int J Gynaecol Obstet. 2013;120(2):119–23.CrossRefPubMed George A, Sabarwal S. Sex trafficking, physical and sexual violence, and HIV risk among young female sex workers in Andhra Pradesh, India. Int J Gynaecol Obstet. 2013;120(2):119–23.CrossRefPubMed
12.
go back to reference WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. 2015. WHO. Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. 2015.
13.
go back to reference Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O’Reilly KR, Koechlin FM, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973–83.CrossRefPubMedPubMedCentral Fonner VA, Dalglish SL, Kennedy CE, Baggaley R, O’Reilly KR, Koechlin FM, et al. Effectiveness and safety of oral HIV preexposure prophylaxis for all populations. AIDS. 2016;30(12):1973–83.CrossRefPubMedPubMedCentral
15.
go back to reference Patterson KB, Prince HA, Kraft E, Jenkins AJ, Shaheen NJ, Rooney JF, et al. Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med. 2011;3(112):112re4.CrossRefPubMedPubMedCentral Patterson KB, Prince HA, Kraft E, Jenkins AJ, Shaheen NJ, Rooney JF, et al. Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med. 2011;3(112):112re4.CrossRefPubMedPubMedCentral
16.
go back to reference Hendrix CW. Exploring concentration response in HIV pre-exposure prophylaxis to optimize clinical care and trial design. Cell. 2013;155(3):515–8.CrossRefPubMed Hendrix CW. Exploring concentration response in HIV pre-exposure prophylaxis to optimize clinical care and trial design. Cell. 2013;155(3):515–8.CrossRefPubMed
17.
go back to reference Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr. 2009;51(1):65–71.CrossRefPubMedPubMedCentral Nachega JB, Hislop M, Nguyen H, Dowdy DW, Chaisson RE, Regensberg L, et al. Antiretroviral therapy adherence, virologic and immunologic outcomes in adolescents compared with adults in southern Africa. J Acquir Immune Defic Syndr. 2009;51(1):65–71.CrossRefPubMedPubMedCentral
19.
go back to reference Napierala Mavedzenge S, Doyle A, Ross D. HIV prevention in young people in sub-Saharan Africa: a systematic review. J Adolesc Health. 2011;49:568–86.CrossRefPubMed Napierala Mavedzenge S, Doyle A, Ross D. HIV prevention in young people in sub-Saharan Africa: a systematic review. J Adolesc Health. 2011;49:568–86.CrossRefPubMed
23.
go back to reference White RG, Hakim AJ, Salganik MJ, Spiller MW, Johnston LG, Kerr L, et al. Strengthening the reporting of observational studies in epidemiology for respondent-driven sampling studies: “STROBE-RDS” statement. J Clin Epidemiol. 2015;68(12):1463–71.CrossRefPubMedPubMedCentral White RG, Hakim AJ, Salganik MJ, Spiller MW, Johnston LG, Kerr L, et al. Strengthening the reporting of observational studies in epidemiology for respondent-driven sampling studies: “STROBE-RDS” statement. J Clin Epidemiol. 2015;68(12):1463–71.CrossRefPubMedPubMedCentral
25.
go back to reference Volz E, Heckathorn DD. Probability based estimation theory for respondent driven sampling. J Off Stat. 2008;24:79–97. Volz E, Heckathorn DD. Probability based estimation theory for respondent driven sampling. J Off Stat. 2008;24:79–97.
34.
go back to reference Garofalo R, Hotton AL, Kuhns LM, Gratzer B, Mustanski B. Incidence of HIV infection and sexually transmitted infections and related risk factors among very young men who have sex with men. J Acquir Immune Defic Syndr. 2016;72(1):79–86.CrossRefPubMedPubMedCentral Garofalo R, Hotton AL, Kuhns LM, Gratzer B, Mustanski B. Incidence of HIV infection and sexually transmitted infections and related risk factors among very young men who have sex with men. J Acquir Immune Defic Syndr. 2016;72(1):79–86.CrossRefPubMedPubMedCentral
35.
go back to reference Card KG, Lachowsky NJ, Cui Z, Shurgold S, Armstrong HL, Rich AJ, et al. An event-level analysis of the interpersonal factors associated with condomless anal sex among gay, bisexual, and other men who have sex with men (MSM) with online-met partners. AIDS Educ Prev. 2017;29(2):154–74.CrossRefPubMed Card KG, Lachowsky NJ, Cui Z, Shurgold S, Armstrong HL, Rich AJ, et al. An event-level analysis of the interpersonal factors associated with condomless anal sex among gay, bisexual, and other men who have sex with men (MSM) with online-met partners. AIDS Educ Prev. 2017;29(2):154–74.CrossRefPubMed
39.
go back to reference Krishnaratne S, Hensen B, Cordes J, Enstone J, Hargreaves JR. Interventions to strengthen the HIV prevention cascade: a systematic review of reviews. Lancet HIV. 2016;3(7):e307–17.CrossRefPubMed Krishnaratne S, Hensen B, Cordes J, Enstone J, Hargreaves JR. Interventions to strengthen the HIV prevention cascade: a systematic review of reviews. Lancet HIV. 2016;3(7):e307–17.CrossRefPubMed
40.
go back to reference Padian NS, Isbell MT, Russell ES, Essex M. The future of HIV prevention. J Acquir Immune Defic Syndr. 2012;60(Suppl 2):S22–6.CrossRefPubMed Padian NS, Isbell MT, Russell ES, Essex M. The future of HIV prevention. J Acquir Immune Defic Syndr. 2012;60(Suppl 2):S22–6.CrossRefPubMed
Metadata
Title
Evaluating the impact of DREAMS on HIV incidence among young women who sell sex: protocol for a non-randomised study in Zimbabwe
Authors
Bernadette Hensen
James R. Hargreaves
Tarisai Chiyaka
Sungai Chabata
Phillis Mushati
Sian Floyd
Isolde Birdthistle
Joanna Busza
Frances Cowan
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2018
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-018-5085-6

Other articles of this Issue 1/2018

BMC Public Health 1/2018 Go to the issue